Found 33 matching trials
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment NA Italian multicenter study, will enroll \~566 pts with oligometastatic hormo...
Show More Location
European Institute of Oncology
Learn More & Join Trial
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP PHASE2 After radical prostatectomy, 30-60% of patients will develop recurrent dise...
Show More Location
Regina Elena National Cancer Institute
Learn More & Join Trial
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study NA An exploratory, feasibility and proof-of-concept study to evaluate the capa...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC PHASE1 The purpose of this trial is to learn more about the effects of AAA602 and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery PHASE2 This randomized phase II trial studies how well androgen receptor antagonis...
Show More Status
Active Not Recruiting
Location
Yale Cancer Center
Learn More & Join Trial
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer. PHASE2 Researchers are looking for a better way to treat men who have high-risk lo...
Show More Location
The Second Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT PHASE2 The purpose of this research study is to test the efficacy of ADT on prosta...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study) PHASE2 ARES is a multicenter, single-arm, phase 2 trial to evaluate the efficacy a...
Show More Location
Nanjing First Hospital, Nanjing Medical University
Learn More & Join Trial
Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer PHASE3 For patients with intermediate-risk prostate cancer plus a predicted risk o...
Show More Location
Kantonsspital Aarau AG
Learn More & Join Trial
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP PHASE2 This is a phase II randomized, open-label study comparing salvage radiother...
Show More Learn More & Join Trial